| The Hobby-Eberly telescope dark energy experiment (HETDEX): description and early pilot survey results GJ Hill, K Gebhardt, E Komatsu, N Drory, PJ MacQueen, J Adams, ... arXiv preprint arXiv:0806.0183, 2008 | 407 | 2008 |
| Evidence for a functional role of endothelial transient receptor potential V4 in shear stress–induced vasodilatation R Köhler, WT Heyken, P Heinau, R Schubert, H Si, M Kacik, C Busch, ... Arteriosclerosis, thrombosis, and vascular biology 26 (7), 1495-1502, 2006 | 365 | 2006 |
| Arterial response to shear stress critically depends on endothelial TRPV4 expression V Hartmannsgruber, WT Heyken, M Kacik, A Kaistha, I Grgic, C Harteneck, ... PloS one 2 (9), e827, 2007 | 304 | 2007 |
| Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis R Köhler, H Wulff, I Eichler, M Kneifel, D Neumann, A Knorr, I Grgic, ... Circulation 108 (9), 1119-1125, 2003 | 295 | 2003 |
| Impaired Endothelium-Derived Hyperpolarizing Factor-Mediated Dilations and Increased Blood Pressure in Mice Deficient of the Intermediate-Conductance Ca2+-Activated K … H Si, WT Heyken, SE Wölfle, M Tysiac, R Schubert, I Grgic, L Vilianovich, ... Circulation research 99 (5), 537-544, 2006 | 275 | 2006 |
| Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension S Brähler, A Kaistha, VJ Schmidt, SE Wölfle, C Busch, BP Kaistha, ... Circulation 119 (17), 2323-2332, 2009 | 267 | 2009 |
| Naphtho [1, 2-d] thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3. 1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and … A Sankaranarayanan, G Raman, C Busch, T Schultz, PI Zimin, J Hoyer, ... Molecular pharmacology 75 (2), 281-295, 2009 | 250 | 2009 |
| Endothelial Ca2+‐activated K+ channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery I Grgic, BP Kaistha, J Hoyer, R Köhler British journal of pharmacology 157 (4), 509-526, 2009 | 223 | 2009 |
| Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets M Félétou, R Köhler, PM Vanhoutte Current hypertension reports 12, 267-275, 2010 | 215 | 2010 |
| Selective blockade of endothelial Ca2+‐activated small‐ and intermediate‐conductance K+‐channels suppresses EDHF‐mediated vasodilation I Eichler, J Wibawa, I Grgic, A Knorr, S Brakemeier, AR Pries, J Hoyer, ... British journal of pharmacology 138 (4), 594-601, 2003 | 213 | 2003 |
| Nitric oxide: orchestrator of endothelium-dependent responses M Félétou, R Köhler, PM Vanhoutte Annals of medicine 44 (7), 694-716, 2012 | 211 | 2012 |
| Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells … I Grgic, I Eichler, P Heinau, H Si, S Brakemeier, J Hoyer, R Köhler Arteriosclerosis, thrombosis, and vascular biology 25 (4), 704-709, 2005 | 190 | 2005 |
| Expression and Function of Endothelial Ca2+-Activated K+ Channels in Human Mesenteric Artery: A Single-Cell Reverse Transcriptase–Polymerase Chain … R Köhler, C Degenhardt, M Kühn, N Runkel, M Paul, J Hoyer Circulation research 87 (6), 496-503, 2000 | 178 | 2000 |
| Renal fibrosis is attenuated by targeted disruption of KCa3. 1 potassium channels I Grgic, E Kiss, BP Kaistha, C Busch, M Kloss, J Sautter, A Müller, ... Proceedings of the National Academy of Sciences 106 (34), 14518-14523, 2009 | 170 | 2009 |
| Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species S Brakemeier, I Eichler, A Knorr, T Fassheber, R Köhler, J Hoyer Kidney international 64 (1), 199-207, 2003 | 125 | 2003 |
| Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets H Wulff, R Köhler Journal of cardiovascular pharmacology 61 (2), 102-112, 2013 | 119 | 2013 |
| Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease R Köhler, BP Kaistha, H Wulff Expert opinion on therapeutic targets 14 (2), 143-155, 2010 | 107 | 2010 |
| Effects of selenium and iodine deficiency on type I, type II and type III iodothyronine deiodinases and circulating thyroid hormones in the rat H Meinhold, A Campos-Barros, B Walzog, R Köhler, F Müller, D Behne Experimental and Clinical Endocrinology & Diabetes 101 (02), 87-93, 1993 | 106 | 1993 |
| Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells R Köhler, S Brakemeier, M Kühn, C Degenhardt, H Buhr, A Pries, J Hoyer Cardiovascular research 51 (1), 160-168, 2001 | 99 | 2001 |
| The potassium channel KCa3. 1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke YJ Chen, HM Nguyen, I Maezawa, EM Grössinger, AL Garing, R Köhler, ... Journal of Cerebral Blood Flow & Metabolism 36 (12), 2146-2161, 2016 | 95 | 2016 |
